Single High Oral Dose Amiodarone for Cardioversion of Recent Onset Atrial Fibrillation

Nadarasa, Kugathasan; Williams, Michael J.A.

doi:10.1016/j.hlc.2012.03.015

Cited by 5 publications

(3 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Doses of oral high-dose amiodarone remain debatable, but patients treated with amiodarone at a dose of 30 mg/kg body weight showed a 98% success rate in returning to normal heart rate [20]. In our case, the patient successfully resumed her normal heart rate after three days of follow-up after receiving a loading dosage of amiodarone 2,000 mg (the patient's body weight was 65 kg).…”

Section: Discussionmentioning

confidence: 57%

High-Dose Oral Amiodarone for Cardioversion of Atrial Fibrillation: A Case Report

Reynaldo¹,

Hamonangan²,

Naomi³

et al. 2023

Cureus

View full text Add to dashboard Cite

With the rising prevalence of atrial fibrillation (AF), it has become a global health problem with increasing complications and high medical costs. Here, we describe the case of a 52-year-old woman with chest discomfort and frequent palpitations for the last few months. A careful clinical and instrumental examination showed that the patient had AF. Sinus rhythm was restored by cardioversion using high-dose oral amiodarone therapy. Although this medication can be an alternative with several advantages over electrical cardioversion in the future, further studies are needed to establish its efficacy and safety profile.

show abstract

Section: Discussionmentioning

confidence: 57%

High-Dose Oral Amiodarone for Cardioversion of Atrial Fibrillation: A Case Report

Reynaldo¹,

Hamonangan²,

Naomi³

et al. 2023

Cureus

View full text Add to dashboard Cite

show abstract

“…Rytm zatokowy uzyskano u 47 chorych w średnim czasie 6 godzin. Nie odnotowano istotnych działań niepożądanych poza złą tolerancją leku u 3 chorych [26].…”

Section: Amiodaronunclassified

Leczenie farmakologiczne napadów migotania przedsionków

et al. 2018

View full text Add to dashboard Cite

“…The European guidelines for the management of atrial fibrillation (4) list as drugs recommended for pharmacological cardioversion amiodarone, flecainide, ibutilide, propafenone, and vernakalant; however, ibutilide is not available in Germany and vernakalant was granted limited marketing authorization ( Table 1). Besides intravenous administration, amiodarone can also be given orally in high doses (30 mg/kg) for cardioversion in recent-onset atrial fibrillation (38). With the "pill in the pocket" approach, oral propafenone or flecainide is used for cardioversion in patients with atrial fibrillation <48 h duration without or with only minor structural heart disease under ECG monitoring.…”

Section: Pharmacological Cardioversionmentioning

confidence: 99%